ZEISS Invests in SeeTrue Eye-Tracking Technology

Oberkochen, Germany | 5 August 2026 | ZEISS Group

ZEISS Ventures led a EUR 2.2 million investment round in SeeTrue Technologies, a Finnish deep-tech company developing miniaturized eye-tracking technology. The investment will accelerate the commercialization of SeeTrue’s ultra-low-power eye-sensing architecture, which is designed to address important challenges in next-generation interfaces for smart optical systems and eyewear.

SeeTrue's proprietary architecture combines miniaturized sensing hardware with optimized embedded processing to enable scalable eye-sensing capabilities with low power consumption and a small hardware footprint. The technology supports gaze-based interaction and attention-aware computing for applications across healthcare-related, industrial, and smart eyewear contexts.

“SeeTrue has developed a differentiated approach to eye tracking. We believe the team is well positioned to address important challenges across vision-based applications and enable more efficient ways of human-machine interaction,” states Prof. Dr. Boris Hofmann, Head of ZEISS Ventures.

“We are working to make eye tracking more compact and suitable for the future of optical and wearable technology. ZEISS’ expertise in optical system design and vision-based technologies provides a valuable perspective as we continue to develop and commercialize our eye-sensing platform,” says Roman Bednarik, CEO and co-founder of SeeTrue Technologies.

The investment round further includes participation from Superhero Capital and North Karelia Growth Fund (NKGF), managed by Redstone Nordics, among other investors. With this investment, ZEISS Ventures underlines its interest in supporting technologies that enable the next generation of smart optical systems and wearable devices.

Press contact Stefanie Fanta

Head of Corporate Communications
ZEISS Group

About ZEISS

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling almost 12 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology, and Consumer Markets (September 30, 2025).

For its customers, ZEISS develops, produces, and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses, and binoculars.

With a portfolio aligned with future growth areas like digitalization, healthcare, and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 14 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.

With over 47,400 employees, ZEISS is active globally in around 50 countries with more than 60 sales and service locations, around 40 research and development facilities, and 30 production facilities worldwide (March 31, 2026). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.

Further information at www.zeiss.com

About ZEISS Ventures

ZEISS Ventures, the corporate venture capital arm of the ZEISS Group, invests in and partners with deep-tech start-ups that have the potential to shape future technologies, markets, and business models beyond ZEISS’ core business. In addition to providing capital, ZEISS Ventures supports portfolio companies with access to ZEISS’ technological and industry expertise, as well as its global network, helping accelerate the development and commercialization of innovative solutions.

Further information at www.zeiss.com/ventures

About SeeTrue Technologies

SeeTrue Technologies Oy, founded in 2018, is a Finnish deep-tech company based in Joensuu, Finland, developing ultra-miniature eye-tracking technology for medical optical systems, vision care, and smart wearables. Built on decades of elite research in photonics, embedded systems, and human-computer interaction, SeeTrue delivers the bio-adaptive sensing layer for the future of spatial computing.

Further information at www.seetruetechnologies.com